DTB Podcast

1. Taxing ill health, and what evidence for intravenous vitamins?

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2023 issue of DTB. They discuss NHS prescription charges in England and the impact they have on people with long-term ill health (https://dtb.bmj.com/content/61/10/146). They talk about a study that assessed the incidence of retinopathy associated with hydroxychloroquine (https://dtb.bmj.com/content/61/10/148). The main article discusses intravenous vitamins and reviews the evidence for th

Sep 27,2023 16:48

2. NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2023 issue of DTB. They discuss concerns over redacted data in NICE appraisal documents (https://dtb.bmj.com/content/61/9/130). They review a placebo-controlled study that assessed the use of spironolactone for women with acne (https://dtb.bmj.com/content/61/9/132). The main article explores anticholinergic burden and the risk of cognitive decline, dementia and increased mortality associ

Aug 30,2023 28:23

3. FeNO and asthma, low-dose aspirin and H pylori eradication, plus finerenone

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the August 2023 issue of DTB. They discuss measurement of fractional exhaled nitric oxide (FeNO) in the management of asthma (https://dtb.bmj.com/content/61/8/114). They review a study that assessed the use of H. pylori eradication in people taking low-dose aspirin (https://dtb.bmj.com/content/61/8/116). The main article explores the evidence for the use of finerenone for CKD associated with type 2 di

Jul 26,2023 24:42

4. July 2023: Whither evidence, COI in guidelines, isotretinoin safety, SGLT2 inhibitors and Utrogestan shortage

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the July 2023 issue of DTB. They discuss evidence-based medicine, access to evidence and increasing use of press releases and social media to present evidence (https://dtb.bmj.com/content/61/7/98). They talk about the safety of isotretinoin (https://dtb.bmj.com/content/61/7/99) and review a study that assessed the accuracy of conflict of interest statements in clinical guidelines (https://dtb.bmj.com/

Jun 28,2023 26:58

5. DTB 60th anniversary podcast interview - Barbara Mintzes

In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. In this podcast, David Phizackerley (DTB deputy editor) talks to Barbara Mintzes (DTB associate editor) who is Associate Professor at the School of Pharmacy and Charles Perkins Centre at the University of Sydney, where she has worked since 2015. Her background is in epidemiology and the main focus of her work is on p

Jun 14,2023 35:47

6. Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the June 2023 issue of DTB. They discuss new guidelines on post-exposure prophylaxisfor varicella or shingles during pregnancy (https://dtb.bmj.com/content/61/6/82). They review the effect of low-dose aspirin on fractures and falls (https://dtb.bmj.com/content/61/6/85), and talk about a study that does not provide meaningful cardiovascular outcome data for inclisiran (https://dtb.bmj.com/content/61/6/

May 31,2023 33:47

7. May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the May 2023 issue of DTB. They celebrate 60 years since DTB became independent from The Medical Letter and discuss what DTB stands for (https://dtb.bmj.com/content/61/5/66). They review a retrospective cohort study involving people taking oral anticoagulants that compared the risk of bleeding and embolic events in new users of NSAIDs with those not prescribed NSAIDs (https://dtb.bmj.com/content/61/5/

Apr 20,2023 25:42

8. When should you take antihypertensive medication. Prescribing for skin conditions in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the April 2023 issue of DTB. They discuss evidence around morning and evening doses of antihypertensive medication (https://dtb.bmj.com/content/61/4/50). They review a study that analysed health technology assessment decisions made in Australia, Canada and England (https://dtb.bmj.com/content/61/4/51) and also talk about managing skin conditions in women who are planning pregnancy or who are pregnant

Mar 22,2023 21:09

9. DTB 60th anniversary podcast interview - Joanna Girling

In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. In this podcast, recorded May 2022, David Phizackerley (DTB's deputy editor) talks to Joanna Girling who is a consultant in obstetric medicine in north London and has been involved with DTB since 2006. Joanna talks about her clinical work, her role with establishing the local maternity network and her involvement in re

Mar 08,2023 36:25

10. Penicillin allergy, lecanemab and Alzeimer’s disease, a new oral contraceptive and statins for all

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the March 2023 issue of DTB. They discuss incorrect penicillin allergy labels and ways that these can be corrected (https://dtb.bmj.com/content/61/3/34). They review clinical trial results for lecanameb in early Alzheimer's disease (https://dtb.bmj.com/content/61/3/37) and also talk about a new combined oral contraceptive that contains estetrol and drospirenone (https://dtb.bmj.com/content/61/3/39). T

Feb 20,2023 30:05

11. Swapping to edoxaban, DOACs in renal impairment, inflammatory rheumatic diseases in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the February 2023 issue of DTB. They discuss concerns over a national initiative in England to transfer people with atrial fibrillation to edoxaban from other DOACs (https://dtb.bmj.com/content/61/2/18). They review a study that examined whether the correct dose of DOAC was used in people with renal impairment (https://dtb.bmj.com/content/61/2/21). They talk about the use of empagliflozin in people wi

Jan 23,2023 25:21

12. DTB 60th anniversary podcast interview - John Dowden

In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB.In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr John Dowden, the editor of Australian Prescriber since 1990. Australian Prescriber (https://www.nps.org.au/australian-prescriber) is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals,

Jan 12,2023 35:56

13. Happy New Year, sad news from Australia, toxocarosis in humans and yet more on valproate safety

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the January 2023 issue of DTB. They begin with another reminder of the concerns over the use of sodium valproate. They talk about the closure of NPS MedicineWise in Australia and the uncertainty over the future of Australian Prescriber - https://dtb.bmj.com/content/61/1/2. They highlight the risk of eye problems with dupilumab - https://dtb.bmj.com/content/61/1/6 (see more links below) and the challe

Dec 20,2022 21:06

14. December 2022 - MHT and ’brain fog’, risks from sodium-containing paracetamol and 2022 revisited

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December 2022 issue of DTB. They discuss cognitive changes that have been reported during the menopause and whether there is a role for MHT (https://dtb.bmj.com/content/60/12/178). They highlight an observational study that found an association between the use of sodium-containing paracetamol and cardiovascular events (https://dtb.bmj.com/content/60/12/181), and talk about the evidence for increas

Nov 22,2022 25:54

15. DTB 60th anniversary podcast interview - Jo Congleton

In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr Jo Congleton, who is a consultant in Integrated Respiratory Care in Brighton and Hove. She is also clinical lead for the Kent, Surrey, Sussex Academic Health and Science Network (AHSN) Respiratory Programme. Her interests are in chronic respiratory c

Nov 03,2022 18:43

16. November 2022 - FMT, methotrexate and COVID vaccine boosters, and Palforzia for peanut allergy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November 2022 issue of DTB. They discuss the use of faecal microbiota transplantation to treat gastrointestinal infections and in particular its role in managing Clostridioides difficile infection (https://dtb.bmj.com/content/60/11/162). They highlight a study that assessed the effect of interrupting methotrexate treatment on COVID-19 booster vaccine response (https://dtb.bmj.com/content/60/11/163

Oct 26,2022 30:02

17. October 2022 - two freebies, advertising woes, paracetamol (again) and standing up to Pharma

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2022 issue of DTB. They discuss whether the language used in announcements from organisations such as NHS England, NICE and the MHRA regarding new medicines is appropriate and highlight concerns that some press releases are at risk of promoting POMs to the public (https://dtb.bmj.com/content/60/10/146). They review a study that assessed the effect that regular doses of paracetamol had on b

Sep 26,2022 32:11

18. September 2022 - healthcare costs, gout, metformin and B12, more on COI and carbetocin

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2022 issue of DTB. They discuss a new national guideline on the management of gout (https://dtb.bmj.com/content/60/9/130). They highlight a safety update on the risk of vitamin B12 deficiency with metformin (https://dtb.bmj.com/content/60/9/131) and provide an overview of a study that analysed the way countries across Europe report payments made by pharmaceutical companies to healthcare

Aug 22,2022 26:30

19. August 2022 - COI, STOMP/STAMP, BP deprescribing, amiodarone and bempedoic acid

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the August 2022 issue of DTB. They discuss progress in reducing use of psychotropic medications in adults and children with a learning disability, autism or both (https://dtb.bmj.com/content/60/8/114). They also provide an overview of a study that assessed the effect of deprescribing antihypertensive medication in older people (https://dtb.bmj.com/content/60/8/118) and talk about a national safety ale

Jul 25,2022 32:05

20. July 2022 - an e-letter, estradiol, APPGs, inclisiran and nitrofurantoin

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the July 2022 issue of DTB. They discuss the proposed reclassification of estradiol vaginal tablets from Prescription Only Medicine to a Pharmacy medicine (https://dtb.bmj.com/content/60/7/98) and review a study that assessed pharmaceutical industry funding of All Party Parliamentary Groups (https://dtb.bmj.com/content/60/7/100). They talk about the evidence for the lipid-lowering drug inc

Jun 28,2022 29:14

21. June 2022 - a complaint, primary care spirometry, paracetamol and frailty, serotonin syndrome

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the June 2022 issue of DTB. They discuss the impact that the cessation of spirometry services in primary care has had on diagnosing obstructive lung disease (https://dtb.bmj.com/content/60/6/82). They highlight two separate patient safety incident reports from the Healthcare Safety Investigation Branch - confusion over the prescribed dose of oral morphine solution and the harm caused by a

May 26,2022 20:55

22. May 2022 - an apology, international drug bulletins, mirtazapine and oral antivirals for covid-19

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the May 2022 issue of DTB. They talk about drug bulletins across the world and the role of the International Society of Drug Bulletins in supporting bulletins and ensuring that they are intellectually and financially independent (https://dtb.bmj.com/content/60/5/66). They review a study that assessed the use of mirtazapine for treating agitation in people with dementia (https://dtb.bmj.com

Apr 26,2022 20:48

23. DTB turns 60! Plus: conflicts of interest, harms from nitrofurantoin and hypertension in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the April 2022 issue of DTB. They talk about DTB's 60th anniversary, the importance of independent scrutiny of new medicines and the need to question how medicines are licensed and used (https://dtb.bmj.com/content/60/4/50). They highlight the benefits of a comprehensive national register of conflicts of interest and discuss a study that compared a quadpill containing low doses of four ant

Mar 22,2022 28:33

24. March 2022 - Paracetamol and blood pressure, greener inhalers, harms from medicines and naldemedine

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the March 2022 issue of DTB. They talk about paracetamol and its effect on blood pressure and discuss progress on moving to inhalers that have less of an impact on the environment (https://dtb.bmj.com/content/60/3/34). The editors review a study that examined harms from medicines (https://dtb.bmj.com/content/60/3/37) and discuss the use of naldemedine in the management of opioid-induced co

Feb 22,2022 22:21

25. Overprescribing, overuse of short-acting beta agonists, inflammatory bowel disease in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the February 2022 issue of DTB. They talk about some of the details from a national report on overprescribing and discuss its implications (https://dtb.bmj.com/content/60/2/18). The editors review a study that highlighted overprescribing of short-acting beta agonists in people with asthma (https://dtb.bmj.com/content/60/2/21). They also discuss an article on prescribing for women of childb

Jan 25,2022 21:36

26. January 2022 - Molnupiravir, potentially harmful prescribing and antidepressant withdrawal reactions

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the January 2022 issue of DTB. They discuss the UK Medicines and Healthcare products Regulatory Agency's decision to license the oral antiviral drug molnupiravir (Lagevrio) and the paucity of publicly available clinical trial data - https://dtb.bmj.com/content/60/1/2. The editors talk about a study that highlighted potentially inappropriate prescribing in middle-aged adults - https://dtb.b

Dec 18,2021 28:11

27. Dec 2021 - Overprescribing, BP monitor accuracy, topical steroids, and bremelanotide and flibanserin

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the December issue of DTB. They discuss a recently published national report on overprescribing of medicines. The editors talk about a study that assessed the accuracy of home blood pressure monitors (https://dtb.bmj.com/content/59/12/179) and highlight a safety alert on topical steroid withdrawal reactions (https://dtb.bmj.com/content/59/12/184). They also review an article on the US Food

Nov 22,2021 22:42

28. November 2021 - Drugs to avoid, penicillin allergy and a new drug for osteoporosis

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the November issue of DTB. They discuss a French initiative that identifies a range of drugs that should not be prescribed (https://dtb.bmj.com/content/59/11/162) and talk about the difficulty of assessing whether patients' penicillin allergy records are correct (https://dtb.bmj.com/content/59/11/163). They also review an article on the use of romosozumab for osteoporosis (https://dtb.bmj.

Oct 24,2021 19:56

29. October 2021 - Desogestrel POM to P, PCI in stable IHD, and migraine in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the October issue of DTB. They discuss the impact of making desogestrel contraceptives available for purchase from pharmacies (https://dtb.bmj.com/content/59/10/146) and talk about the role of percutaneous coronary intervention in patients with stable ischaemic heart disease (https://dtb.bmj.com/content/59/10/150). They also review an article about managing migraine in pregnancy (https://d

Sep 29,2021 21:50

30. September 2021: Aducanumab for Alzheimer’s, antibiotics, shared-decision making, and dental health

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the September issue of DTB. They discuss the US FDA's controversial decision to license aducanumab for Alzheimer's disease (https://dtb.bmj.com/content/59/9/130) and consider barriers to prescribing shorter courses of antibiotics in primary care (https://dtb.bmj.com/content/59/9/131). The editors also highlight the impact that some medicines have on oral health and dental treatment (https:

Aug 23,2021 23:51

31. August 2021. Community pharmacy discharge medicines service: a step towards improved patient safety?

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the August issue of DTB (https://dtb.bmj.com/content/59/8). The editors talk about the MHRA's decision to reverse the EMA's decision and allow boron-containing chloramphenicol eye drops to be used in children aged below 2 years. They discuss a scheme in England that allows hospital staff to refer patients who would benefit from extra guidance around their medicines regimen for support from

Jul 26,2021 20:56

32. July 2021 - Chloramphenicol eye drops, boron, infants and fertility

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the July issue of DTB. The editors catch up on developments with proposals for all doctors in the UK to provide financial and non-financial declarations of interest. They discuss the problem of boron in chloramphenicol eye drop products and the impact on treating children aged under 2 years (https://dtb.bmj.com/content/59/7/98). The editors also talk about PPIs for persistent throat sympt

Jun 23,2021 26:47

33. June 2021 - COVID-19 vaccination in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) review the June issue of DTB. The list of articles mentioned in this podcast:The Editorial “COVID-19 vaccination in pregnancy” - https://dtb.bmj.com/content/59/6/82DTB select “Stepping down asthma treatment” - https://dtb.bmj.com/content/59/6/85Review “Prescribing for pregnancy: managing diabetes” - https://dtb.bmj.com/content/59/6/88Republished case report “Euglycaemic diabetic ketoacidosis in a 43-year-old wom

May 24,2021 25:19

34. May 2021 - Time for transparency

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) review the May issue of DTB. In light of the "First do no harm" report, the editorial discusses the need for a mandatory register of payments made by pharmaceutical and medical device companies to healthcare professionals, healthcare organisations and patient support organisations (https://dtb.bmj.com/content/59/5/66). The editors talk about the BTS guideline on long-term use of macrolides (https://dtb.bmj.com/

Apr 26,2021 20:33

35. April 2021 - Asthma, a disease of variability

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) review the April issue of DTB. The editorial discusses variability in the management of people with severe asthma (https://dtb.bmj.com/content/59/4/50). The editors talk about a summary of an article on changes in prescribing of statins (https://dtb.bmj.com/content/59/4/53). The main article explores the use of aspirin for pre-eclampsia (https://dtb.bmj.com/content/59/4/56) and the case report is of a patient w

Mar 22,2021 27:02

36. March 2021 - Opioid safety: striking the right balance

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) review the March issue of DTB (https://dtb.bmj.com/content/59/3). The editorial discusses a national safety alert that highlighted the risk of dependence associated with prolonged use of opioids for non-cancer pain and a proposal that all opioid medicines in the UK carry the warning "can cause addiction" (https://dtb.bmj.com/content/59/3/34). The editors talk about an article on the rationale and science behind

Feb 23,2021 23:13

37. February 2021 - Why vaccines matter

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) discuss the February issue of DTB. This includes an editorial that highlights the benefits associated with the human papillomavirus (HPV) and herpes zoster vaccination programmes (https://dtb.bmj.com/content/early/2021/01/11/dtb.2020.000048). The editors talk about a cohort study, which found that many older people who had recently been prescribed a calcium-channel blocker for hypertension were subsequently give

Jan 25,2021 23:40

38. January 2021 - COVID-19 vaccination: we need more than the ‘mum test’

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) discuss the January issue of DTB (https://dtb.bmj.com/content/59/1). This includes an editorial that highlights the urgent need for more information for the public to support the national COVID-19 vaccination programme (https://dtb.bmj.com/content/59/1/2). The editors talk about the importance of knowing how patients use their medicines at home (https://dtb.bmj.com/content/59/1/3)and discuss advice for populatio

Jan 04,2021 22:00

39. COVID-19 vaccines - getting the information right

In this podcast James Cave (Editor in Chief) and David Phizackerley (Deputy Editor) discuss some of the challenges associated with the national COVID-19 vaccination programme. In particular, they highlight the importance of making information on the vaccines’ safety and efficacy available to help people make an informed decision on vaccination.Read the paper: https://dtb.bmj.com/content/early/2020/11/24/dtb.2020.000071Please subscribe to the DTB podcast to get episodes automatically downloaded t

Nov 27,2020 13:04

40. December 2020 - Hype and hope of bedtime dosing of antihypertensives

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) preview the December issue of DTB. This includes an editorial that discusses the results of a study that suggested that people who took antihypertensive medication at bedtime had a lower risk of a cardiovascular event. The editors talk about a threat to the supply of the Priadel brand of lithium carbonate. They also discuss the use of esketamine for treatment-resistant depression. This month's case report invol

Nov 25,2020 24:09

41. November 2020 - Chronic pain (analgesia armageddon)

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) preview the November issue of DTB. This includes an editorial that focuses on the National Institute of Health and Care Excellence's draft guideline on the management of chronic pain, and in particular, the approach to treating chronic primary pain (https://dtb.bmj.com/content/58/11/162). The editors talk about a new patient-held steroid emergency card that has been introduced to help healthcare staff identify a

Oct 26,2020 15:35

42. October 2020 - Making medicines safer?

A socially distanced podcast with James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) previewing the October issue of DTB. This includes an editorial that discusses the harms caused by medicines and medical devices and highlights concerns over proposals to speed up the UK licensing process for medicines. The editors talk about an article that looks at the influence of pharmaceutical marketing. They also review three new medicines used to prevent migraines. This month's case repo

Sep 28,2020 21:03

43. September 2020 - Dilemmas in commissioning biological therapies

As we continue with our socially distanced DTB podcasts James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the September issue of DTB. This includes an editorial discussing the challenges facing commissioning organisations when changes to clinical practice or market authorisation have a significant impact on how biological therapies can be used. The editors highlight a study that showed a lack of adherence to guidelines on direct oral anticoagulant dosing

Aug 24,2020 19:08

44. August 2020 - Virtual revolution

Another socially distanced DTB podcast features James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) who provide an overview of the August issue of DTB. This includes an editorial discussing the changes that have taken place in general practices and the new ways of working that have been developed during the coronavirus pandemic (https://dtb.bmj.com/content/58/8/114). The main article reviews the evidence for using vitamin D and calcium in older people who have osteoporosis (https

Jul 27,2020 19:28

45. Low-dose aspirin for prevention of pre-eclampsia: when over the counter just isn’t

Another socially distanced DTB podcast features James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor), who provide an overview of the July issue of DTB. This includes an editorial that discusses some of the challenges in supplying low-dose aspirin to pregnant women for prevention of pre-eclampsia, a DTB Forum article by Margaret McCartney on some of the challenges to evidence-based medicine during the coronavirus pandemic and a DTB Select update on the safety of ibuprofen in people

Jun 22,2020 18:40

46. Deprescribing in the time of COVID-19

With the coronavirus pandemic restrictions still in place, this socially distanced DTB podcast features James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor), who provide an overview of the June issue of DTB. This includes an editorial that discusses whether clinicians should be deprescribing some medicines during the pandemic, and a summary of the EMA's advice on the use of drugs that affect the renin-angiotensin system in people who have COVID-19. The main article looks at the ga

May 27,2020 21:36

47. Improving consultations with children and adolescents, plus treating Covid-19 with ibuprofen

As the UK continues to be in lockdown because of the coronavirus pandemic, this podcast only features David Phizackerley, DTB's Deputy Editor, who provides a brief overview of the May issue of DTB. This includes an editorial that discusses the challenges facing clinicians in involving children and young people in decisions about their healthcare; a summary of the EMA's advice on the use of ibuprofen in people who have Covid-19; and an article on the development of shared care prescribing guideli

Apr 27,2020 04:53

48. April 2020 - Lung volume in COPD: when less is more

In April's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss lung volume reduction surgery for patients with emphysema-predominant COPD (https://dtb.bmj.com/content/58/4/50). They highlight the results of a trial of low-dose amitriptyline for chronic low back pain (https://dtb.bmj.com/content/58/4/53), discuss the use of depot triamcinolone injection for hay fever (https://dtb.bmj.com/content/58/4/57), and talk about a case in which dapagliflozin was th

Mar 24,2020 14:39

49. March 2020 - Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risks

In March's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the decision to extend the license for dapagliflozin 5 mg tablets to include use by people with type 1 diabetes and highlight concerns over the incidence of diabetic ketoacidosis. They review an article on managing asthma before and during pregnancy and talk about a case of partial nephrogenic diabetes insipidus associated with lithium therapy.Read the full March issue: dtb.bmj.com/content/58/

Feb 26,2020 10:10

50. February 2020 - Registering our interest

In February's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the impact of conflicts of interest and highlight the need to establish comprehensive registers of conflicts of interest for healthcare professionals, healthcare providers and patient support groups. They briefly review an article on melatonin for jet lag (a longer version is available here: https://soundcloud.com/bmjpodcasts/melatonin-for-jet-lag?in=bmjpodcasts/sets/dtb-podcast), discuss

Jan 27,2020 10:05

51. Melatonin for jet lag

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a formulation of melatonin that has been licensed in the UK for the management of jet lag. The editors review the evidence for its effectiveness in reducing symptoms of jet lag and consider whether it should be available from the National Health Service. Read the article here: http://dx.doi.org/10.1136/dtb.2019.000074.Please subscribe to the DTB Podcast to get episodes automatically downloaded to

Dec 20,2019 08:54

52. January 2020 - Polypharmacy and deprescribing: just ask the patient

In January's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the burden of overprescribing and discuss how to tackle some of the barriers to deprescribing (https://dtb.bmj.com/content/58/1/2). They also review an article on the place of aspirin for primary prevention of cardiovascular disease (https://dtb.bmj.com/content/58/1/3), highlight an article on prescribing for pregnancy for women with mental health issues (https://dtb.bmj.com/content/58/1/8)

Dec 16,2019 10:08

53. December 2019 - Has the polypill finally proven its worth?

In December's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the results of a recent study that assessed the effect of a combination pill containing aspirin, atorvastatin, enalapril and hydrochlorothiazide on major cardiovascular outcomes - https://dtb.bmj.com/content/57/12/178. The editors discuss prasterone, a newly introduced treatment for vulvar and vaginal atrophy - https://dtb.bmj.com/content/57/12/185. They also review a case report of retrog

Nov 25,2019 10:29

54. November 2019 - Meeting QOF hypertension targets but failing the patient

In November's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss whether primary care targets for managing blood pressure control in older people are achievable or desirable. The editors also introduce the first of a series of articles that consider therapeutic challenges when preparing for pregnancy and highlight some of the key issues that should be considered for all women as part of pre-pregnancy care. They also review a case report of apixaban-induc

Oct 23,2019 11:14

55. October 2019 -Medicines optimisation: time to review fibrates?

In October's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss wide variation in the use of fibrates and the need for clinicians to consider whether their prescribing of fibrates is up to date and appropriate for their patients. The editors also talk about the evidence for fibrates in primary and secondary prevention of cardiovascular disease, highlight recent changes in the BNF and review a case of severe acute ocular hypertension following pulsed meth

Sep 23,2019 08:40

56. September 2019 - Social prescribing: right idea, wrong name?

In September's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the roll out of social prescribing across the NHS in England. The editors also talk about a new formulation of naloxone for emergency treatment of opioid overdose in adults and review a case that involved successful thrombolysis for acute ischaemic stroke after using idarucizumab to reverse the action of dabigatran etexilate.To read any of the September articles, please visit: https://dtb.

Aug 27,2019 10:38

57. August 2019: Time to speed up the diagnosis of pre-eclampsia

In August's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss pre-eclampsia and the benefit of measuring the level of placental growth factor to help speed up diagnosis. The editors also talk about the challenge of communicating evidence to patients and review a case of complex encephalopathy arising from the combination of opioids and gabapentin.Read the full issue: https://dtb.bmj.com/content/57/8.

Jul 22,2019 05:48

58. July 2019: It is hard work being a patient

In July's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the work that patients have to do to manage their health and how this is not recognised by clinical guidelines. The editors also talk about the non-drug management of low back pain and discuss a case of metformin-associated lactic acidosis precipitated by liraglutide use.Read the full issue: dtb.bmj.com/content/57/7.

Jun 19,2019 07:19

59. June 2019: If the drugs don’t work

In June's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the European Medicines Agency's decision to amend the licence for omega-3 fatty acid medicines so that they will no longer be authorised for secondary prevention after myocardial infarction. The editors also review ospemifene, a new medicine for the management of vulvar and vaginal atrophy and discuss a case of delusional infestation in the treatment of ADHD with atomoxetine.Read the full issu

May 29,2019 09:01

60. May 2019: The new GP contract - an opportunity for drugs and therapeutics

In May's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the opportunities for drugs and therapeutics in the new GP contract for England. The editors also talk about the management of chronic cough and discuss a case of acute liver failure associated with a short course of nitrofuantoin.Read the issue online: https://dtb.bmj.com/content/57/5.

May 15,2019 08:34

61. April 2019: DOAC dosing in renal impairment

In April's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the challenges of prescribing direct acting oral anticoagulant (DOAC) drugs for people with renal impairment. The editors also talk about the use of saline nasal irrigation and discuss central sensitisation syndrome.Read the issue online: https://dtb.bmj.com/content/57/4.

Mar 20,2019 10:53

62. March 2019: A new direction for diabetes

In March's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) get excited about the impact that the results of the Direct study could have on the management of type 2 diabetes. The editors also discuss the combination of doxylamine and pyridoxine for the treatment of nausea and vomiting in pregnancy and consider the role of primary care in supporting patients who are taking clozapine.Read the full issue: https://dtb.bmj.com/content/57/3.

Feb 25,2019 13:49

63. February 2019: The past, present and future of inhaled corticosteroids for COPD

In February's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of inhaled corticosteroids in the management of COPD (https://dtb.bmj.com/content/57/2/18). The editors also consider subclinical hypothyroidism in pregnancy (https://dtb.bmj.com/content/57/2/22) and discuss Gilbert’s syndrome (https://dtb.bmj.com/content/57/2/27).Read the full issue: https://dtb.bmj.com/content/57/2

Jan 21,2019 08:48

64. January 2019: Challenging the supremacy of intravenous antibiotics

In January's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss whether intravenous antibiotics are always needed. The editors also consider the challenge of stopping antipsychotic drug treatment in people with intellectual disability and review a case of angioedema of the small bowel caused by lisinopril.Read the issue: dtb.bmj.com/content/57/1.

Dec 14,2018 09:37

65. December 2018: Information on medicines for patients

In December's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the conditional authorisation process for medicines and the need for clearer labelling of medicines that have been through this approval processes. The editors also consider common sources of information on medicines for patients and review a case of interstitial lung disease associated with adalimumab.Read the issue: https://dtb.bmj.com/content/56/12.

Nov 16,2018 07:44

66. November 2018: Travelling with medicines

In November's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a recent study that compared a coordinated, multi-professional, multi-faceted primary care approach to managing people with multiple long-term conditions with usual general practice care. The editors also consider problems faced by patients who need to travel overseas with controlled drugs and review a case of splenic rupture associated with rivaroxaban.Read the November issue: https://dtb.

Oct 17,2018 09:38

67. October 2018: atrial fibrillation, opioids for chronic pain and over-the-counter sildenafil

In October's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the place of population screening for atrial fibrillation and the need for more evidence to support a change in national policy (https://dtb.bmj.com/content/56/10/112). The editors also consider problems associated with long-term opioid use in the management of chronic pain (https://dtb.bmj.com/content/56/10/118). Please watch the video about Michael's moving story on this subject at dtb.bmj

Oct 08,2018 10:48

68. Here’s your New DTB!

In September's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the changes to DTB that have taken place this month and discuss the background and rationale to these changes. Read this month's editorial: https://dtb.bmj.com/content/56/9/98.The editors also consider the place for monitored dosage systems (https://dtb.bmj.com/content/56/9/102) and discuss the evidence for using labetalol as a first-line treatment option for hypertension in preg

Sep 12,2018 08:56

69. August 2018: what’s your position on giving birth?

In the August's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the results of an awarding research paper that assessed the impact of spending the second stage of labour either in a recumbent or upright position. Read the editorial: https://dtb.bmj.com/content/56/8/85.The editors also consider nutritional support in primary care (https://dtb.bmj.com/content/56/8/90) and discuss new licensing pathways that provide faster access to medicines (https://dt

Aug 06,2018 11:14

70. July 2018: managing herbal-drug interactions

In July’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the risk of drug interactions with herbal medicines.Read the editorial: https://dtb.bmj.com/content/56/7/73.The editors also review the evidence for ocrelizumab for relapsing MS and early primary progressive MS (https://dtb.bmj.com/content/56/7/80), and discuss the role of metformin in people with type 1 diabetes (https://dtb.bmj.com/content/56/7/78).

Jul 11,2018 13:07

71. June 2018: Antidepressants - there is no news

In the June’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss whether a recently published large meta-analysis on the effectiveness of antidepressants tells us anything new. Read the editorial here: dtb.bmj.com/content/56/6/61.The editors also review the evidence for the combination analgesic of tramadol/dexketoprofen (dtb.bmj.com/content/56/6/66), and question the dose of paracetamol for older people (dtb.bmj.com/content/56/6/69).

Jul 02,2018 10:52

72. May 2018: Does pulmonary rehabilitation need more PR?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the evidence for pulmonary rehabilitation for COPD and highlight the need for more publicity for its benefits. Read the editorial here: http://dtb.bmj.com/content/56/5/49.The editors also review the evidence for safinamide for Parkinson’s disease (http://dtb.bmj.com/content/56/5/54), and discuss the use of bezlotoxumab, a monoclonal antibody licensed for the prevention of recurrence of Cl

May 09,2018 11:59

73. April 2018: STOMP - time to make more noise

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a national campaign in England that is tackling the inappropriate use of antipsychotic and antidepressant medicines in people with learning or intellectual disability.Read the article: http://dtb.bmj.com/content/56/4/37.The editors also review the evidence for a once-daily triple inhaler for maintenance treatment for adults with moderate to severe COPD (http://dtb.bmj.com/content/56/4/42)

Apr 11,2018 15:33

74. March 2018: Do hypertension guidelines put the person first?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss some of the difficulties in implementing clinical guidelines for the management of elevated blood pressure and the potential impact of changes in the threshold for a diagnosis of hypertension (http://dtb.bmj.com/content/56/3/25).The editors also review the evidence for dupliumab for the treatment of moderate-to-severe atopic dermatitis in adults (http://dtb.bmj.com/content/56/3/30) and di

Mar 12,2018 11:16

75. February 2018: Clinical guidelines - more PDAs please

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the importance of developing patient decision aids to support the implementation of clinical guidelines (http://dtb.bmj.com/content/56/2/13). The editors also review the evidence for cladribine for the treatment of highly active relapsing multiple sclerosis (http://dtb.bmj.com/content/56/2/21) and discuss the latest levonorgestrel IUS device to be marketed for contraception (http://dtb.bm

Feb 09,2018 13:10

76. January 2018: No alchemy for obesity

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the importance of exercise, diet and behaviour modification in the management of obesity and consider the limitations of anti-obesity drugs. http://dtb.bmj.com/content/56/1/1The editors also review the evidence for ▼patiromer, a cation exchange polymer, that has recently been marketed for the management of hyperkalaemia - http://dtb.bmj.com/content/56/1/6 and discuss the management of gou

Jan 02,2018 12:37

77. December 2017: Shared care protocols – have they had their day?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the challenge of prescribing specialist drugs in primary care and highlight problems associated with the use of shared care protocols. http://dtb.bmj.com/content/55/12/133The editors also review the evidence for an inhaler containing beclometasone, formoterol and glycopyrronium that has recently been licensed for the management of COPD - http://dtb.bmj.com/content/55/12/138 - and discuss

Dec 04,2017 12:34

78. November 2017: Prescribing in pregnancy - stop stopping and start planning

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the challenges associated with prescribing for long-term conditions in women who are pregnant and raise concerns that medicines may be stopped inappropriately. Read the editorial here: http://dtb.bmj.com/content/55/11/121.The editors also review a combination product containing naltrexone and bupropion that is licensed for the management of obesity - http://dtb.bmj.com/content/55/11/126 -

Nov 06,2017 14:29

79. October 2017: Flagging risk

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the fragmented approach to communicating additional risk minimisation measures for medicines. Article available here: http://dtb.bmj.com/content/55/10/1.The editors also review the long-term safety of PPIs (http://dtb.bmj.com/content/55/10/117) and discuss the use of the live attenuated influenza vaccine for children (http://dtb.bmj.com/content/55/10/114).

Oct 09,2017 12:11

80. September 2017: Vitamin D and adolescents: a forgotten ‘at risk’ group?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss vitamin D deficiency in teenagers and highlight the challenge of implementing national recommendations on vitamin D intake in young people. Full article here: http://dtb.bmj.com/content/55/9/1. The editors also review the management of scarlet fever (http://dtb.bmj.com/content/55/9/102.2) and consider two drugs (baricitinib and tofacitinib) recently licensed for the management of rheumato

Sep 04,2017 11:20

81. August 2017: What price drugs online?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the supply of medicines from online primary care services (article here: http://dtb.bmj.com/content/55/8/85).The editors also review two recently licensed drugs: eluxadoline, a mixed opioid receptor agonist/antagonist for irritable bowel syndrome (http://dtb.bmj.com/content/55/8/90) and an oral formulation of glycopyrronium (http://dtb.bmj.com/content/55/8/93) for severe drooling in child

Jul 26,2017 12:02

82. July 2017: The good, the bad and the ugly

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the role of Electroconvulsive Therapy (ECT) in the management of psychiatric disorders. Article here: http://dtb.bmj.com/content/55/7/1.The editors also discuss the use of liraglutide for obesity (related article here: http://dtb.bmj.com/content/55/7/78)and highlight some of the challenges associated with the management of people with clinical features of both asthma and COPD (http://dtb.

Jul 05,2017 13:38

83. June 2017: Turning the tide of high-dose inhaled corticosteroids

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of high-dose inhaled corticosteroids in asthma and COPD. The editors also highlight some of the challenges associated with the management of superficial venous thrombosis of the leg and discuss the use of carbohydrate deficient transferrin as a biomarker for the assessment of chronic alcohol use.Read more about the DTB's June 2017 issue: http://dtb.bmj.com/content/55/6#DTBSelect.E

Jun 05,2017 11:18

84. May 2017: Rational rationing in the NHS?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss attempts by the NHS in England to target £400m of prescribing expenditure that is reported to be wasted on a range of products that are considered to be of low value. Editorial available here: http://dtb.bmj.com/content/55/5/49The editors also review the evidence for the use of off-label testosterone supplementation in menopausal women (http://dtb.bmj.com/content/55/5/57) and discuss a ne

May 03,2017 13:04

85. April 2017: Prevention of type 2 diabetes - where do you draw the line?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a national initiative to identify and manage people at high risk of developing type 2 diabetes. Full article available here: http://dtb.bmj.com/content/55/4/37.The editors also review the evidence for an HRT product containing bazedoxifene and conjugated oestrogens (http://dtb.bmj.com/content/55/4/42) and discuss a new formulation of lidocaine and prilocaine licensed for treatment of prem

Mar 28,2017 13:49

86. March 2017: Better PrEParation needed?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss some of the implications related to funding of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). They consider the Court of Appeal decision on funding and the role of clinical and health economic evaluations for preventative treatments. Full article available here: http://dtb.bmj.com/content/55/3/25. The editors also review the evidence for a new formulation of de

Mar 14,2017 12:58

87. February 2017: Spironolactone - potion or poison?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the risk of hyperkalaemia associated with spironolactone in people with heart failure. They consider recent advice issued by the Medicines and Healthcare products Regulatory Agency and highlight the importance of regular monitoring of potassium and renal function.The editors also review the evidence for daclizumab, a drug for relapsing multiple sclerosis, and provide a brief introduction

Feb 06,2017 14:33

88. January 2017: Sore throat test and treat - a £34 million question?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a proposal from NHS England to introduce a sore throat test-and-treat service in community pharmacies. They review the evidence on the management of sore throat and examine the assumptions that underpin the proposed service.The editors also discuss pitolisant, a new drug for narcolepsy, and review the evidence for LAMA/LABA inhaler combinations for people with COPD.Read more about this is

Jan 09,2017 15:47

89. December 2016: Wise words on prescription of medicines and treatment decisions

"Clarity begins at home". In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) start by remembering DTB's founding editor, Andrew Herxheimer's golden rules for prescribing.The DTB editors also discuss 'gliptins' in the management of diabetes and evidence from recent cardiovascular outcome studies, as well as, psychological interventions for eating disorders.The full editorial is available here: http://dtb.bmj.com/content/early/2016/12/05/dtb.2016.12.0439.f

Nov 21,2016 11:55

90. November 2016: Rubella immunisation. Check vaccination history

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss changes to the rubella screening programme and the need to ensure that MMR vaccinations are up to date, especially in younger women born outside the UK. Read the full editorial here: http://dtb.bmj.com/content/54/11/121.full.The editors also discuss prescribing information sources (http://dtb.bmj.com/content/54/11/129.full) and the evidence on the management of difficult to treat severe a

Nov 07,2016 11:20

91. October 2016: the dangers of a quicker authorisation process for drugs

Why should we worry about the new European Medicines Agency (EMA) pilot project to accelerate the approval of new drugs? James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the October issue Editorial, that looks at the pros and cons of this new trend both in the USA and Europe.Read the full article here: http://dtb.bmj.com/content/54/10/109.full.Also in this podcast:• the use of the new antibiotic Fosfomycin trometamol for the treatment of acute uncomplicated low

Oct 21,2016 09:16

92. September 2016: Last orders for nalmefene in the management of alcohol dependence?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of nalmefene in the management of alcohol dependence. Although the drug has been approved for use in the NHS, DTB's editorial highlights limitations of the evidence supporting its use and discusses concerns raised by three groups of researchers. Currently, the NHS in England spends £20,000 per month on the drug in primary care.Read the full editorial here: http://dtb.bmj.com/conte

Aug 24,2016 12:38

93. August 2016: Better guidelines. Capsaicin for diabetic neuropathy. Excipients in medicines

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the presentation of guidelines and ways of making them more accessible. Read the full editorial here: http://dtb.bmj.com/content/54/8/85.fullThere’s also an evaluation of the use of capsaicin for diabetic peripheral neuropathy. Article accessible here: http://dtb.bmj.com/content/54/8/90.fullThe DTB editors also talk about medicines, excipients and dietary intolerances. Article accessible

Aug 08,2016 18:08

94. July 2016: Where next for rationing medicines? Vitamins during pregnancy: a big marketing campaign?

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss proposals to stop the prescription of some medicines and foods in order to help manage the deficit in NHS budgets. Full article available here: http://dtb.bmj.com/content/early/2016/07/07/dtb.2016.7.0409.full.The podcast also includes a review of an article about the effects of the antidiabetic drug empagliflozin on cardiovascular outcomes, as well as a review of an article on the use of vitamin

Jul 07,2016 15:45

95. June 2016: Problems with botanicals; a new drug for heart failure; frailty and deprescribing

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of herbal products. They also develop the highlights of the articles: Articles: "Frailty, polypharmacy and deprescribing" and "Sacubitril valsartan for heart failure"Read all the articles featured here: dtb.bmj.com/content/54/6.toc

May 25,2016 19:43

96. May 2016: supporting learning disabilities; new drugs for orthostatic hypotension and ADHD

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss health checks for young people with learning disabilities and review two recently licensed drugs - one for treating orthostatic hypotension and the other for managing ADHD in children and adolescents.Read all the articles featured here: dtb.bmj.com/content/54/5.toc

May 09,2016 16:58

97. April 2016: the cancer drugs fund for England, restless legs and animal-derived content in medicines

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the Cancer Drug Fund for England; review a new indication for the combination of oxycodone and naloxone for the management of restless legs syndrome; and consider the impact of animal-derived medicines.Read the articles featured here: Editorial: NICE and the cancer drugs fund for England Articles: 1. Targinact for restless legs syndrome 2. Implications of religious and cultural beliefs on selec

Apr 06,2016 16:21

98. March 2016 Issue: Testosterone replacement therapy and a new antidepressant

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss testosterone replacement therapy; review the new antidepressant vortioxetine; and consider the impact of drugs on the QT interval.The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.Read all the articles featured here: dtb.bmj.com/content/54/3.toc

Mar 01,2016 14:27

99. February 2016 issue: Too many options, too little choice in COPD?

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the proliferation of new drugs for managing COPD; review two new lipid-lowering drugs (evolocumab and alirocumab) from a new class (proprotein convertase subtilisin/kexin type 9 inhibitors); and consider total ankle joint replacement.The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/54/2.toc

Feb 04,2016 13:32

100. January 2016 issue: NHS Health Checks, Adolescent Adherence and Management of Dry Eye

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss NHS Health Checks in England; the challenges facing young people taking medicines for long-term conditions; and the management of dry eye disease.The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/54/1.toc

Jan 08,2016 11:23

101. December 2015 issue: Cost-effectiveness of drugs on long term conditions

In this podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss stopping rules for medicines used to manage long-term conditions; naloxegol for the management of opioid-induced constipation that has failed to respond to laxative therapy; and the plethora of new drugs and preparations for the management of open-angle glaucoma in adults.The DTB podcast is recorded monthly to coincide with the release of the print issue of DTB.Read all the articles featured here

Dec 01,2015 13:29

102. In this issue: November 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the November 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/11.toc

Nov 09,2015 11:20

103. In this issue: September 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the September 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/9.toc

Oct 02,2015 08:56

104. In this issue: October 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the October 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/10.toc

Oct 02,2015 10:54

105. In this issue: August 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the August 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/8.toc

Aug 18,2015 15:05

106. In this issue - July 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the July 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/7.toc

Jul 07,2015 15:06

107. In this issue - June 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the June 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/6.toc

Jul 07,2015 09:21

108. In this issue - May 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the May 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/5.toc

Jun 29,2015 13:39

109. In this issue - April 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the April 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/4.toc

May 19,2015 14:01

110. In this issue - February 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the February 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/3.toc

Apr 22,2015 18:10

111. In this issue - March 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the March 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/3.toc

Mar 23,2015 12:58

112. In this issue - January 2015

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the January 2015 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/53/1.toc

Jan 28,2015 12:03

113. In this issue - December 2014

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the December 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/12.toc

Dec 05,2014 14:49

114. In this issue - November 2014

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and Caroline Blaine (DTB Clinical Editor) discuss the contents of the October 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/11.toc

Nov 11,2014 17:17

115. In this issue - October 2014

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the October 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/10.toc

Oct 07,2014 14:39

116. In this issue - September 2014

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the September 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/9.toc

Sep 16,2014 21:42

117. In this issue - August 2014

Welcome to the DTB podcast, which is recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the August 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/8.toc

Jul 30,2014 18:50

118. In this issue - July 2014

Welcome to a new series of DTB podcasts that are being recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the July 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/7.toc

Jul 16,2014 16:13

119. In this issue: June 2014

Welcome to a new series of DTB podcasts that are being recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the June 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/6.toc

Jun 09,2014 15:51

120. In this issue - May 2014

Welcome to a new series of DTB podcasts that are being recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the May 2014 issue of DTB.Read all the articles featured here: http://dtb.bmj.com/content/52/5.toc

May 16,2014 16:23

121. In this issue - April 2014

Welcome to a new series of DTB podcasts that are being recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the April 2014 issue of DTB:Metformin OK in CKD?Lubiprostone for chronic constipation in adultsManagement of adults with PTSD part II: drugs and other interventionsEMA to review efficacy of emergency contraceptivesRead them all here: dtb.bmj.com/content/52/4.toc

May 07,2014 14:48

122. In this issue - March 2014

Welcome to a new series of DTB podcasts that are being recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the February 2014 issue of DTB:Editorial - Describing deprescribing Article - Dapoxetine for premature ejaculationArticle - Management of adults with PTSD DTB Select - Further restrictions on the use of strontium ranelateRead all the articles here: dtb.bmj.com/content/52/3

Mar 13,2014 12:03

123. In this issue - February 2014

Welcome to a new series of DTB podcasts that are being recorded monthly to coincide with the release of the print issue of DTB.James Cave (DTB Editor in Chief) and David Phizackerley (DTB Deputy Editor) discuss the contents of the February 2014 issue of DTB: Editorial - What price change? Article - Interactions with herbal products: what do we know?Article - Azelastine and fluticasone nasal spray: any advantage?DTB Select - Cardiovascular risk with medicines containing sodiumdtb.bmj.comRead all

Feb 13,2014 14:07

124. In this issue - August 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.HIV services - what role for primary care?DTB Select: 7 - August 2011The place of routine HIV testingWhat role for ▼prucalopride in constipation?

May 02,2013 12:04

125. In this issue - July 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Adults with ADHD: ignored and under treatedDTB Select: 6 - July 2011Management of acute infective conjunctivitisSystemic lupus erythematosus - an update

May 02,2013 17:35

126. Sunscreens

This month’s issue considers whether use of sunscreens helps to prevent skin cancer.This podcast focuses on these topics and related issues, and involves discussion between Brian Diffey (Emeritus Professor of Photobiology at Newcastle University), Ike Iheanacho and David Phizackerley (Editor and Deputy Editor, DTB, respectively).Accompanying this is an editorial that questions recent public health guidance on sunscreens from the National Institute for Health and Clinical Excellence.Articles:Suns

May 02,2013 19:31

127. In this issue - June 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Sunscreen SPFs: clear as daylight?DTB Select: 5 | June 2011▼Ticagrelor for acute coronary syndrome?Do sunscreens have a role in preventing skin cancer?

May 02,2013 11:27

128. In this issue - May 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:PPIs: too much of a good thing?DTB Select: 4 | May 2011Managing diffuse oesophageal spasmNanomedicines - what are they?Update: Artemisinins in malaria treatment in the UK

May 02,2013 09:39

129. In this issue - April 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Herbal medicine - all changeDTB Select: 3 | April 2011Curing patients with liver metastases from colorectal cancerRoflumilast for severe COPD?

May 02,2013 10:06

130. In this issue - March 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Don’t bank on savingsDTB Select: 2 | March 2011OTC tranexamic acid for heavy menstrual bleeding – an updatePost-exposure prophylaxis for HIVPain management programmes for chronic pain?

May 02,2013 07:19

131. In this issue - February 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:PolypillomaniaDTB Select: 1 ∣ February 2011Reducing NSAID-induced gastrointestinal complicationsBotox for chronic migraine

May 02,2013 11:27

132. In this issue - January 2011

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Playing the numbers gameCan beta-blockers be used for people with COPD?OTC tranexamic acid for heavy menstrual bleeding?Which oral aminosalicylate for ulcerative colitis?

May 02,2013 06:23

133. In this issue - December 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:60 and countingWhich insulin, regimen and device in type 2 diabetes?Targinact – opioid pain relief without constipation?What role for topical antibacterials in acne?Don’t Drop Mixtard 30 campaign: Thank you

May 02,2013 07:53

134. In this issue - November 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Price, pragmatism and prasugrelSeasonal flu vaccination for healthcare workers?Dronedarone for atrial fibrillation?Artemisinins in malaria treatment in the UKDon’t Drop Mixtard 30: what people say

May 02,2013 08:29

135. In this issue - October 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Back to the futureThe use of ‘specials’ in primary careOTC tamsulosin for benign prostatic hyperplasiaDo corticosteroids improve outcome in meningitis?Mixtard 30: time’s running out

May 02,2013 09:19

136. In this issue - September 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:The price you payManagement of corticosteroid-induced osteoporosisWhat role for Qlaira in contraception?A guide to health economic evaluationsDon’t Drop Mixtard 30 campaign

May 02,2013 09:06

137. Mixtard 30

As part of DTB’s “Don’t Drop Mixtard” campaign, this podcast discusses the implications of the drug’s withdrawal from the UK market for people with diabetes, healthcare professionals and the NHS.The conversation involves Dr Wing May Kong (consultant endocrinologist and member of the DTB Editorial Board), Cathy Moulton (Care Adviser at Diabetes UK), and Dr Ike Iheanacho and David Phizackerley (Editor and Deputy Editor of DTB, respectively).To find out more about the campaign, including DTB’s peti

May 02,2013 18:00

138. In this issue - August 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Mixtard 30 - going, going, gone?Ulipristal – a new emergency contraceptive pillManagement of fibromyalgiaAgomelatine for major depressive episodes

May 02,2013 05:52

139. In this issue - July 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Money, money, moneyPreventing exacerbations in COPDFebuxostat for goutHow medical devices are regulated in the UK

May 02,2013 08:59

140. In this issue - June 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Why pregabalin? DTB 2010; 48: 61Acupuncture for tension-type headaches and migraine DTB 2010; 48: 62 - 5Misoprostol for postpartum haemorrhage DTB 2010; 48: 66 - 9Testosterone for ‘late-onset hypogonadism’ in men? DTB 2010; 48: 69 - 72

May 02,2013 09:38

141. In this issue - May 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Alcoholic neglect DTB 2010; 48: 49Liraglutide for type 2 diabetes? DTB 2010; 48: 50 - 3Grazax for hay fever – what’s new? DTB 2010; 48: 54 - 6I.V. immunoglobulin therapy for infectious diseases DTB 2010; 48: 57 - 60

May 02,2013 05:53

142. In this issue - April 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:The computer says “no”? DTB 2010; 48: 37Silver dressings – do they work? DTB 2010; 48: 38 - 42Vagus nerve stimulation for epilepsy DTB 2010; 48: 42 - 45Herbal medicines – what do clinicians know? DTB 2010; 48: 46 - 47

May 02,2013 05:30

143. Herbal medicines – what do clinicians know?

This month, we publish the results of a Drug and Therapeutics Bulletin Survey on Herbal Medicines, an online research designed to explore healthcare professionals’ knowledge of and attitudes towards herbal medicines. In this podcast, Dr Ike Iheanacho, DTB Editor, and David Phizackerley, DTB Deputy Editor, discuss the results of the survey, and issues related to the use and regulation herbal medicines, with Dr Linda Anderson, Principal Pharmaceutical Assessor at the MHRA and Mr Michael McIntyre,

May 02,2013 10:48

144. In this issue - March 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:A risky business? DTB 2010; 48: 25Using NSAIDs in cardiovascular disease DTB 2010; 48: 26 - 29Managing primary hyperparathyroidism in primary care DTB 2010; 48: 30 - 33Body surface area for adjustment of drug dose DTB 2010; 48: 33 - 36

May 02,2013 05:59

145. In this issue - February 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Patient safety first? DTB 2010; 48: 13Management of community-associated MRSA DTB 2010; 48: 14 - 19▼Pregabalin for generalised anxiety disorder DTB 2010; 48: 19 - 22A change of units for HbA1c DTB 2010; 48: 23 - 24Conversion chart for HbA1c values

May 02,2013 08:44

146. In this issue - January 2010

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:More on high street mole checks DTB 2010; 48: 1Management of medication overuse headache DTB 2010; 48: 2 - 6Cognitive behavioural therapy for schizophrenia DTB 2010; 48: 6 - 9Tocilizumab for rheumatoid arthritis DTB 2010; 48: 9 - 12

May 02,2013 05:16

147. In this issue - December 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:C. difficile outside hospital DTB 2009; 47: 133Managing gastro-oesophageal reflux in infants DTB 2009; 47: 134 - 137Strong opioids for osteoarthritis in primary care? DTB 2009; 47: 138 - 141Generic prescribing in epilepsy DTB 2009; 47: 141 - 144

May 02,2013 05:34

148. In this issue - November 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Uncommon knowledge DTB 2009; 47: 121Aspirin for primary prevention of cardiovascular disease? DTB 2009; 47: 122 - 125Over-the-counter weight loss with orlistat? DTB 2009; 47: 125 - 127Management of seasonal affective disorder DTB 2009; 47: 128 - 132

May 02,2013 07:47

149. In this issue - October 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Generically speaking DTB 2009; 47: 109Does BNP testing aid diagnosis of heart failure? DTB 2009; 47: 110 - 113Imiquimod for superficial and in situ skin malignancy DTB 2009; 47: 113 - 116Anticoagulation with dabigatran or rivaroxaban DTB 2009; 47: 116 - 120

May 02,2013 03:35

150. Tamiflu - the wrong message?

The widespread use of oseltamivir (Tamiflu) has been a key strategy in tackling the H1N1 ‘swine flu’ pandemic in the UK. However, there have been growing concerns about the communication of this approach and rationale behind the policy itself. In this podcast Dr Ike Iheanacho, DTB editor, discusses the policy with two members of the DTB editorial board, Dr Paul Caldwell, a general practitioner and Dr Mahdad Noursadeghi, an infectious diseases consultant. This is an extension of our September 200

May 02,2013 20:16

151. In this issue - September 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Tamiflu − the wrong message? DTB 2009; 47: 97Self-monitoring for patients on warfarin? DTB 2009; 47: 98 - 101Non-drug management of chronic low back pain DTB 2009; 47: 102 - 108Correction: How to misinform patients DTB 2009; 47: 108

May 02,2013 03:09

152. In this issue - August 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:How to misinform patients DTB 2009; 47: 85Management of carpal tunnel syndrome DTB 2009; 47: 86 - 89So, what exactly is a cytokine? DTB 2009; 47: 89 - 91Ezetimibe – an update DTB 2009; 47: 91 - 95Understanding statistical terms: 5 – systematic reviews and meta-analyses DTB 2009; 47: 95 - 96

May 02,2013 03:31

153. In this issue - July 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Only in England DTB 2009; 47: 73Melatonin for primary insomnia? DTB 2009; 47: 74 - 77Which approach for first trimester miscarriage? DTB 2009; 47: 77 - 80What are excipients doing in medicinal products? DTB 2009; 47: 81 - 84

May 02,2013 04:14

154. In this issue - June 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Real costs of end-of-life drugs DTB 2009; 47: 61Management of benign paroxysmal positional vertigo DTB 2009; 47: 62 - 66Interferon-gamma release assays and TB diagnosis DTB 2009; 47: 67 - 70Understanding statistical terms: 4 – Diagnostic tests DTB 2009; 47: 71 - 72

May 02,2013 01:27

155. Real costs of end-of-life drugs

In January 2009, NICE began a policy for valuing the use of drugs for extending life in people with a short life-expectancy. This development arose from concerns that NICE had been denying patients life-extending treatments because they were too expensive. However, the new policy also raises important ethical and moral dilemmas. In this podcast Dr Martin Duerden, General Practitioner and member of the DTB editorial board, and Dr Ike Iheanacho, DTB Editor, discuss this policy and the issues it ra

May 02,2013 22:00

156. In this issue - May 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:The mad world of epilepsy drugs DTB 2009; 47: 49Update on treatments for head lice DTB 2009; 47: 50 - 52What role for colesevelam in cardiovascular prevention? DTB 2009; 47: 53 - 5Why look at an SPC? DTB 2009; 47: 56 - 58Understanding statistical terms: 3 DTB 2009; 47: 59 - 60

May 02,2013 02:12

157. In this issue - April 2009

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:What are you on? DTB 2009; 47: 37Preventing recurrent venous thromboembolism. DTB 2009; 47: 38 - 41Drospirenone in HRT? DTB 2009; 47: 41 - 4The licensing of medicines in the UK. DTB 2009; 47: 45 – 48

May 02,2013 02:23

158. What are you on?

Drugs prescribed and administered solely under specialist care or as part of clinical trials, without being specifically recorded in GPs’ prescribing systems, can have serious consequences for patient safety. Here, in our second podcast, Dr Pawan Randev, general practitioner and primary care cancer lead, and Dr Ike Iheanacho, DTB Editor, discuss these issues. This is an extension of our April 2009 Editorial, What are you on? (DTB 2009; 47: 37).

May 02,2013 16:24

159. Mole checks on the high street

Early diagnosis in malignant melanoma is crucial to long-term survival. With this knowledge have come new imaging technologies for assessing suspect pigmented lesions. These, in turn, have led to privately run ‘high street mole clinics’. Here, in our first podcast, Dr Julia Schofield, Principal Lecturer in Dermatology at the University of Hertfordshire and member of the DTB editorial board, and Dr Ike Iheanacho, DTB Editor, discuss the place of these clinics. This is an extension of our March 20

May 02,2013 13:13

All Episodes (159) From new to old From new to old From old to new

All Episodes (159)

From new to old

From new to old From old to new